ada standards of care 2025 obesity pharmacotherapy glp-1 recommendations Medical in Diabetes: Updates! Although the ADA Standards of Care is a living document throughout the 2025 Concise Clinical Guidance: An – Diabetes Standards of Care (2025)

For liver health, GLP-1 medications improve hepatic fat accumulation and liver enzyme levels, showing promise for non-alcoholic fatty liver disease treatment ^40

The FDAs latest warning, issued earlier this month, also addressed recent reports that a company planned to sell a knockoff version of the Wegovy pill

What usually matters more is consistency

In contrast, Beta-1 receptors are mainly distributed in the heart, and can increase myocardial contractility, self-regulation, and conduction function

Diabetologia 53 , S342 (2010)

These symptoms are thought to result from slowed gastric emptying and altered gut motility